Leitch A M
Division of Surgical Oncology, Department of Surgery, University of Texas Southwestern Medical Center, Dallas, Texas 75235-9155, USA.
Surg Oncol Clin N Am. 1999 Oct;8(4):657-72, vi.
In randomized trials, screening mammography has been shown to reduce breast cancer mortality. There has been controversy, however, about the segment of the population that should be screened and the frequency at which screening should occur. This article details these controversial issues. The benefits that have been realized from mammography screening in overall breast cancer mortality and diagnosis of earlier stage cancers are also reviewed.
在随机试验中,乳腺钼靶筛查已被证明可降低乳腺癌死亡率。然而,对于应该接受筛查的人群范围以及筛查的频率一直存在争议。本文详细阐述了这些有争议的问题。还回顾了乳腺钼靶筛查在总体乳腺癌死亡率及早期癌症诊断方面所取得的益处。